Lamivudine Tablet, Film Coated
Product Images NDC 51407-866

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 51407-866). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-866-60lb (Lamivudine (HBV) 100mg)

This is a description of lamivudine tablets, indicated for Hepatitis B Virus (HBV), each containing 100 mg of the active ingredient. The pharmacist is instructed to provide patient information along with the medication. It is advised to store the tablets at temperatures between 20°C to 25°C and protect them from moisture. The package insert should be consulted for the usual dosage. The tablets are marketed by GSMS, Incorporated in Camarillo, California.*

FDA Label Image

Chemical-structure.jpg (Chemical Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.